CP
RCEL icon

CenterBook Partners’s Avita Medical RCEL Stock Holding History

CenterBook Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-145,347
Closed -$2.33M – 447
2024
Q1 		$2.33M Buy
145,347
+128,269
+751% +$2.08M 0.16% 216
2023
Q4 		$234K Buy
+17,078
New +$196K 0.03% 370

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CenterBook Partners's RCEL Position: Q2 2024 in Review

CenterBook Partners sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 145,347 shares — an estimated $2.33M sold.

CenterBook Partners first reported a position in RCEL in Q4 2023 and held it in 2 quarters. The position peaked at $2.33M in Q1 2024. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • CenterBook Partners reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • CenterBook Partners sold 145,347 Avita Medical shares in Q2 2024, an estimated $2.33M.
  • CenterBook Partners first reported a position in Avita Medical in Q4 2023 and held it in 2 quarters.
  • CenterBook Partners's Avita Medical position peaked at $2.33M in Q1 2024.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on CenterBook Partners's 13F filing for Q2 2024, filed 12 Aug 2024.